Founder and Director Cleveland Clinic Minority Men's Health Center
Urology
Dr. Charles S. Modlin, MD
|
|
Give Review
Charles Modlin is an expert in the field of Urology. He attended Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Charles S. Modlin, MD is a published physician. He published 59 publications, including: 'Transplantation of pediatric en bloc cadaver kidneys into adult recipients.' Charles Modlin is registered with Medicare and accepts Medicare payments.
Publications
- Race effects on pathological and functional outcomes after robotic partial nephrectomy in a single academic tertiary care center.
- Financial Hardship, Unmet Medical Need, and Health Self-Efficacy Among African American Men.
- Intraoperative management of Renal allograft venous-calyceal fistula and incidental Renal cell carcinoma during Renal transplantation: a case report.
- Transvaginal hybrid natural orifice transluminal surgery robotic donor nephrectomy: first clinical application.
- Renal allograft capsular repair surgical technique to reduce allograft discard rates of Kidneys with capsular injury.
- Addressing disparities in health care.
- Racial disparities in urologic health care.
- Rates of biochemical remission remain higher in black men compared to white men after radical Prostatectomy despite similar trends in Prostate specific antigen induced...
- Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhib...
- Current management of transplant Renal artery stenosis: clinical utility of duplex Doppler ultrasonography.
- The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on Renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free im...
- Fate of donor Kidney: laparoscopic versus open technique.
- The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 Kidney-transplant recipients.
- Culture, race, and disparities in health care.
- Disparities in health-related internet use among african american men, 2010.
- A phase I trial of recombinant Human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
- Intraoperative placing of drains decreases the incidence of lymphocele and deep vein thrombosis after Renal transplantation.
- Ipsilateral dual-Kidney transplantation using organs declined by other centers.
- Simultaneous vs. sequential laparoscopic bilateral native nephrectomy and Renal transplantation.
- Hyperfiltration nephropathy as a cause of late graft loss in Renal transplantation.
- The effect of two different cyclosporine formulations on the long-term progression to Chronic rejection in renal allograft recipients.
- Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
- Trends in PSA, age and prostate Cancer detection among black and white men from 1990-2006 at a tertiary care center.
- The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after Kidney transplantation.
- Factors related to delayed graft function after laparoscopic live donor nephrectomy.
- Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control Kidneys.
- Laparoscopic live donor nephrectomy has equivalent early and late Renal function outcomes compared with open donor nephrectomy.
- USTVS survey of laporoscopic donor nephrectomy.
- A systematic approach to minimizing wound problems for de novo sirolimus-treated Kidney transplant recipients.
- Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free Kidney transplant immunosuppression.
- Expression of IL-8 during reperfusion of Renal allografts is dependent on ischemic time.
- Salvage of compromised renal vessels in Kidney transplantation using third-party cadaveric extenders: impact on posttransplant anti-HLA antibody formation.
- Posttransplant diabetes mellitus in Kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
- Graft outcomes of living donor Renal transplantations in elderly recipients.
- Long-term results with single pediatric donor Kidney transplants in adult recipients.
- Early and late impact of a positive flow cytometry crossmatch on graft outcome in primary Renal transplant.
- Association between a positive flow cytometry crossmatch and the development of Chronic rejection in primary renal transplantation.
- A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of Kidney transplants.
- Significance of serum creatinine pattern and area under the creatinine versus time curve during the first acute Renal transplant rejection.
- U-stitch ureteroneocystostomy: a new Renal transplantation ureteral reimplantation technique associated with reduced urologic complications.
- Quantitative assessment of the first acute rejection as a predictor of Renal transplant outcome.
- Acute colonic pseudo-obstruction (Ogilvie's syndrome) after Renal transplantation.
- The development of Chronic renal allograft rejection may be predicted early following transplantation.
- Monitoring of CMV Infection after renal transplantation: serology, culture, and viral DNA detection by hybrid capture.
- Acute rejection and the flow cytometry crossmatch.
- Cyclosporine disposition and long-term renal function in a 500-pound Kidney transplant recipient.
- Transplantation of pediatric en bloc cadaver Kidneys into adult recipients.
- A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk Kidney transplant recipients.
- Kidneys from living donors with renal vascular disease may be safely used for transplantation.
- Should obese patients lose weight before receiving a Kidney transplant?
- The use of Kidneys from living donors with renal vascular disease: expanding the donor pool.
- The use of expanded criteria cadaver and live donor Kidneys for transplantation.
- Determinants of Chronic renal allograft rejection in cyclosporine-treated recipients.
- Transplantation into the long-term defunctionalized Bladder.
- Testicular seminoma originating in an undescended testis in a Renal allograft recipient.
- Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superAntigen.
- Transfer of endogenous retroviral superAntigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
- Culturally competent methods to promote organ donation rates among African-Americans using venues of the Bureau of Motor Vehicles.
Schools
Northwestern University The Feinberg School Of Medicine
Nyu
Cleve Clin Found
Procedures Preformed
- Cystometry
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Excision of Testicular Lesion
- Kidney and Ureter Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
NYU School of Medicine -
Northwestern University Feinberg School of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1578527891 | |
| NPPES Provider LastName | MODLIN | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Urology | |
| Total Claim Count | 288.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 4.51 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578527891 |
| Last Name Of The Provider | MODLIN |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Holly K. Wyneski, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard B. Goldman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtenay K. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel A. Shoskes, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Steven Campbell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irma J. Lengu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Adonis K. Hijaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrienne Quirouet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth K. Ferry, MD |
|
|
Dr. Cesar E. Ercole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anand M. Patel, MD |
|
|
Dr. Aisha K. Taylor, MD |